Archive: European Medicines Agency

Showing 331 to 340 of 575 entries

	Title
2011-01-01	Report on the survey of all paediatric uses of medicinal products in Europe: Established according to article 42-43 of Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for Paediatric use Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Report on the Pilot EMA-FDA GCP Initiative, September 2009 – March 2011 Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Guide to the European Medicines Agency Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Workshop on antibacterials. Report of the workshop Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Outcome report on pilot phase for participation of patient representatives in Scientific Advisory Group (SAG) meetings Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Pandemic report and lessons learned: Outcome of the European Medicines Agency’s activities during the 2009 (H1N1) flu pandemic Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Trends in the sales of veterinary antimicrobial agents in nine European countries: Reporting period 2005-2009 Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	2010 pharmacovigilance legislation: Strengthening the monitoring of medicines Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	International workshop: Meeting report. Draft reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted in third countries and submitted in marketing-authorisation to the EMA, London, 6-7 September 2011 Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)